RecruitingNot ApplicableNCT07181356

Effects of Long-term Remote Ischemic Preconditioning on Clinical Outcome in Patients With Acute Myocardial Infarction


Sponsor

Henan Institute of Cardiovascular Epidemiology

Enrollment

2,146 participants

Start Date

Jan 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

At present, there are 290 million cardiovascular patients in China, including 11 million patients with coronary heart disease. Remote ischemic preconditioning(RIPC) may play an effective endogenous cardiac protection.This study will explore whether long-term use of RIPC in patients with AMI after PCI and non interventional therapy can reduce the incidence of major adverse cardiovascular cerebrovascular events(MACCE) and improve clinical outcomes and long-term prognosis.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients with acute myocardial infarction were diagnosed in accordance with the criteria of the "Global Unified Definition of Fourth Myocardial Infarction"

Exclusion Criteria7

  • The patients could not tolerate RIPC or RIPerC
  • Aortic dissection, coronary artery aneurysm, coronary artery fistula and other systemic organic diseases
  • The uncontrolled systolic blood pressure and diastolic blood pressure of severe hypertension were 180 mmHg and 120 mmHg respectively
  • severe liver dysfunction (bilirubin > 20 mmol / L, prothrombin time > 2.0 ratio)
  • Severe renal insufficiency (GFR < 30 ml / min / 1.73 m2);
  • patients taking nicorandil and other drugs affecting microcirculation
  • pregnant

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRIPerC

Each 40 minutes treatment time, 10 minutes as a cycle (cuff inflated to 200 mmHg and maintained for 5 minutes, then deflated for 5 minutes to start the next cycle), a total of 4 cycles

OTHERRIPC

Each 40 minutes treatment time, 10 minutes as a cycle (cuff inflated to 200 mmHg and maintained for 5 minutes, then deflated for 5 minutes to start the next cycle), a total of 4 cycles


Locations(1)

Fuwai Central China Cardiovascular Hospital

Zhengzhou, Henan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07181356


Related Trials